Medical and economic impact of autoimmune hepatitis

Jayant A. Talwalkar, W. Ray Kim

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

AIH is a chronic liver disease that has been associated with hepatic failure and death in the absence of liver transplantation. As a result, AIH imparts significant medical and economic burdens on affected patients and health care delivery systems, respectively. The use of accepted methodologies for outcomes and health services research has identified emerging information on the epidemiology and natural history, HRQoL, and resource utilization for similar autoimmune chronic liver diseases such as PBC and PSC. Similar efforts are needed in AIH, and they are supported on the basis of existing data which suggest similar levels of disease burden compared to PBC and PSC. As a result, the ability to plan for disease management strategies in AIH that require the allocation of scarce resources will be feasible.

Original languageEnglish (US)
Pages (from-to)361-379
Number of pages19
JournalClinics in Liver Disease
Volume6
Issue number3
StatePublished - Aug 2002

Fingerprint

Insemination, Artificial, Homologous
Medical Economics
Autoimmune Hepatitis
Liver Diseases
Chronic Disease
Delivery of Health Care
Resource Allocation
Health Services Research
Liver Failure
Disease Management
Natural History
Liver Transplantation
Patient Care
Epidemiology

ASJC Scopus subject areas

  • Hepatology

Cite this

Talwalkar, J. A., & Kim, W. R. (2002). Medical and economic impact of autoimmune hepatitis. Clinics in Liver Disease, 6(3), 361-379.

Medical and economic impact of autoimmune hepatitis. / Talwalkar, Jayant A.; Kim, W. Ray.

In: Clinics in Liver Disease, Vol. 6, No. 3, 08.2002, p. 361-379.

Research output: Contribution to journalArticle

Talwalkar, JA & Kim, WR 2002, 'Medical and economic impact of autoimmune hepatitis', Clinics in Liver Disease, vol. 6, no. 3, pp. 361-379.
Talwalkar, Jayant A. ; Kim, W. Ray. / Medical and economic impact of autoimmune hepatitis. In: Clinics in Liver Disease. 2002 ; Vol. 6, No. 3. pp. 361-379.
@article{68ee862e29834d6fbbb87a9ea89ba502,
title = "Medical and economic impact of autoimmune hepatitis",
abstract = "AIH is a chronic liver disease that has been associated with hepatic failure and death in the absence of liver transplantation. As a result, AIH imparts significant medical and economic burdens on affected patients and health care delivery systems, respectively. The use of accepted methodologies for outcomes and health services research has identified emerging information on the epidemiology and natural history, HRQoL, and resource utilization for similar autoimmune chronic liver diseases such as PBC and PSC. Similar efforts are needed in AIH, and they are supported on the basis of existing data which suggest similar levels of disease burden compared to PBC and PSC. As a result, the ability to plan for disease management strategies in AIH that require the allocation of scarce resources will be feasible.",
author = "Talwalkar, {Jayant A.} and Kim, {W. Ray}",
year = "2002",
month = "8",
language = "English (US)",
volume = "6",
pages = "361--379",
journal = "Clinics in Liver Disease",
issn = "1089-3261",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Medical and economic impact of autoimmune hepatitis

AU - Talwalkar, Jayant A.

AU - Kim, W. Ray

PY - 2002/8

Y1 - 2002/8

N2 - AIH is a chronic liver disease that has been associated with hepatic failure and death in the absence of liver transplantation. As a result, AIH imparts significant medical and economic burdens on affected patients and health care delivery systems, respectively. The use of accepted methodologies for outcomes and health services research has identified emerging information on the epidemiology and natural history, HRQoL, and resource utilization for similar autoimmune chronic liver diseases such as PBC and PSC. Similar efforts are needed in AIH, and they are supported on the basis of existing data which suggest similar levels of disease burden compared to PBC and PSC. As a result, the ability to plan for disease management strategies in AIH that require the allocation of scarce resources will be feasible.

AB - AIH is a chronic liver disease that has been associated with hepatic failure and death in the absence of liver transplantation. As a result, AIH imparts significant medical and economic burdens on affected patients and health care delivery systems, respectively. The use of accepted methodologies for outcomes and health services research has identified emerging information on the epidemiology and natural history, HRQoL, and resource utilization for similar autoimmune chronic liver diseases such as PBC and PSC. Similar efforts are needed in AIH, and they are supported on the basis of existing data which suggest similar levels of disease burden compared to PBC and PSC. As a result, the ability to plan for disease management strategies in AIH that require the allocation of scarce resources will be feasible.

UR - http://www.scopus.com/inward/record.url?scp=0036694462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036694462&partnerID=8YFLogxK

M3 - Article

C2 - 12362573

AN - SCOPUS:0036694462

VL - 6

SP - 361

EP - 379

JO - Clinics in Liver Disease

JF - Clinics in Liver Disease

SN - 1089-3261

IS - 3

ER -